158 related articles for article (PubMed ID: 36551683)
1. Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells.
Champion JD; Dodd KM; Lam HC; Alzahrani MAM; Seifan S; Rad E; Scourfield DO; Fishel ML; Calver BL; Ager A; Henske EP; Davies DM; Kelley MR; Tee AR
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551683
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
[TBL] [Abstract][Full Text] [Related]
3. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.
Singh-Gupta V; Zhang H; Banerjee S; Kong D; Raffoul JJ; Sarkar FH; Hillman GG
Int J Cancer; 2009 Apr; 124(7):1675-84. PubMed ID: 19101986
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.
Dodd KM; Yang J; Shen MH; Sampson JR; Tee AR
Oncogene; 2015 Apr; 34(17):2239-50. PubMed ID: 24931163
[TBL] [Abstract][Full Text] [Related]
6. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer.
Mijit M; Kpenu E; Chowdhury NN; Gampala S; Wireman R; Liu S; Babb O; Georgiadis MM; Wan J; Fishel ML; Kelley MR
Redox Biol; 2024 Feb; 69():102977. PubMed ID: 38056311
[TBL] [Abstract][Full Text] [Related]
7. mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development.
Peng H; Liu J; Sun Q; Chen R; Wang Y; Duan J; Li C; Li B; Jing Y; Chen X; Mao Q; Xu KF; Walker CL; Li J; Wang J; Zhang H
Oncogene; 2013 Sep; 32(39):4702-11. PubMed ID: 23108404
[TBL] [Abstract][Full Text] [Related]
8. RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells.
Mijit M; Wireman R; Armstrong L; Gampala S; Hassan Z; Schneeweis C; Schneider G; Zhang C; Fishel ML; Kelley MR
Front Oncol; 2022; 12():826617. PubMed ID: 35402225
[TBL] [Abstract][Full Text] [Related]
9. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
10. APE1/Ref-1 as a Novel Target for Retinal Diseases.
Heisel C; Yousif J; Mijiti M; Charizanis K; Brigell M; Corson TW; Kelley MR
J Cell Signal; 2021; 2(2):133-138. PubMed ID: 34322687
[TBL] [Abstract][Full Text] [Related]
11. Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.
Shah F; Logsdon D; Messmann RA; Fehrenbacher JC; Fishel ML; Kelley MR
NPJ Precis Oncol; 2017; 1():. PubMed ID: 28825044
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex.
Lu Y; Zhang EY; Liu J; Yu JJ
Orphanet J Rare Dis; 2020 Aug; 15(1):209. PubMed ID: 32807195
[TBL] [Abstract][Full Text] [Related]
13. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
14. Activation of the integrated stress response (ISR) pathways in response to Ref-1 inhibition in human pancreatic cancer and its tumor microenvironment.
Mijit M; Boner M; Cordova RA; Gampala S; Kpenu E; Klunk AJ; Zhang C; Kelley MR; Staschke KA; Fishel ML
Front Med (Lausanne); 2023; 10():1146115. PubMed ID: 37181357
[TBL] [Abstract][Full Text] [Related]
15. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
16. RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1.
Lin W; Wan X; Sun A; Zhou M; Chen X; Li Y; Wang Z; Huang H; Li H; Chen X; Hua J; Zha X
Mol Ther Oncolytics; 2021 Dec; 23():387-401. PubMed ID: 34853810
[TBL] [Abstract][Full Text] [Related]
17. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract][Full Text] [Related]
18. Feedback of hypoxia-inducible factor-1alpha (HIF-1alpha) transcriptional activity via redox factor-1 (Ref-1) induction by reactive oxygen species (ROS).
Kobayashi Y; Oguro A; Imaoka S
Free Radic Res; 2021 Feb; 55(2):154-164. PubMed ID: 33410354
[TBL] [Abstract][Full Text] [Related]
19. Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway.
Yoshida S; Hong S; Suzuki T; Nada S; Mannan AM; Wang J; Okada M; Guan KL; Inoki K
J Biol Chem; 2011 Sep; 286(37):32651-60. PubMed ID: 21784859
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
